Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcome of Use of a Novel Modulator of Oxidative Phosphorylation on Kidney Function in Patients With Chronic Kidney Disease

NCT07150338 is registered in ClinicalTrials.gov with Neukidney Inc. as lead sponsor.

NCT NCT07150338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07150338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcome of Use of a Novel Modulator of Oxidative Phosphorylation on Kidney Function in Patients With Chronic Kidney Disease
Lead sponsor
Neukidney Inc.
Phase
Observational
Overall status
Completed
Start date
May 20, 2021
Completion date
November 20, 2022
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease (stage 3-4), chronic kidney disease (stages 4 and 5), proteinuria